FR2512670B1 - Capsules contenant le principe actif d'un allergene et procede pour leur preparation - Google Patents

Capsules contenant le principe actif d'un allergene et procede pour leur preparation

Info

Publication number
FR2512670B1
FR2512670B1 FR8208989A FR8208989A FR2512670B1 FR 2512670 B1 FR2512670 B1 FR 2512670B1 FR 8208989 A FR8208989 A FR 8208989A FR 8208989 A FR8208989 A FR 8208989A FR 2512670 B1 FR2512670 B1 FR 2512670B1
Authority
FR
France
Prior art keywords
capsules containing
allergen
preparation
active ingredient
choconstritive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8208989A
Other languages
English (en)
French (fr)
Other versions
FR2512670A1 (fr
Inventor
Gaetano Melillo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorio Farmaceutico Lofarma Sas
Original Assignee
Laboratorio Farmaceutico Lofarma Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorio Farmaceutico Lofarma Sas filed Critical Laboratorio Farmaceutico Lofarma Sas
Publication of FR2512670A1 publication Critical patent/FR2512670A1/fr
Application granted granted Critical
Publication of FR2512670B1 publication Critical patent/FR2512670B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR8208989A 1981-06-04 1982-05-19 Capsules contenant le principe actif d'un allergene et procede pour leur preparation Expired FR2512670B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT22136/81A IT1220979B (it) 1981-06-04 1981-06-04 Capsule contenenti un allergene e procedimento per la loro preparazione

Publications (2)

Publication Number Publication Date
FR2512670A1 FR2512670A1 (fr) 1983-03-18
FR2512670B1 true FR2512670B1 (fr) 1986-12-19

Family

ID=11192020

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8208989A Expired FR2512670B1 (fr) 1981-06-04 1982-05-19 Capsules contenant le principe actif d'un allergene et procede pour leur preparation

Country Status (13)

Country Link
US (1) US4681752A (cg-RX-API-DMAC7.html)
EP (1) EP0067130B1 (cg-RX-API-DMAC7.html)
JP (1) JPS57212114A (cg-RX-API-DMAC7.html)
AT (1) ATE20518T1 (cg-RX-API-DMAC7.html)
CA (1) CA1207663A (cg-RX-API-DMAC7.html)
CH (1) CH650925A5 (cg-RX-API-DMAC7.html)
DE (1) DE3271829D1 (cg-RX-API-DMAC7.html)
DK (1) DK153920C (cg-RX-API-DMAC7.html)
FR (1) FR2512670B1 (cg-RX-API-DMAC7.html)
GR (1) GR76810B (cg-RX-API-DMAC7.html)
IL (1) IL65875A (cg-RX-API-DMAC7.html)
IT (1) IT1220979B (cg-RX-API-DMAC7.html)
NO (1) NO156275C (cg-RX-API-DMAC7.html)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6024983A (en) * 1986-10-24 2000-02-15 Southern Research Institute Composition for delivering bioactive agents for immune response and its preparation
US5075109A (en) * 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
US5204113A (en) * 1987-04-09 1993-04-20 Fisons Plc Pharmaceutical compositions containing pentamidine
JP2770970B2 (ja) * 1987-04-09 1998-07-02 フアイソンズ・ピーエルシー ペンタミジンを含有する医薬組成物
US5021554A (en) * 1989-02-24 1991-06-04 Eli Lilly And Company Process for protein particle size reduction using a fluid-energy mill
WO1992016554A1 (en) * 1991-03-14 1992-10-01 The University Of Melbourne Protein allergens of the species cynodon dactylon
CA2097932A1 (en) * 1991-10-11 1993-04-12 Shojiro Yamazaki Antibody containing composition
US5641510A (en) * 1994-07-01 1997-06-24 Genentech, Inc. Method for treating capsules used for drug storage
EP0711804A3 (de) 1994-11-14 1999-09-22 Ciba SC Holding AG Kryptolichtschutzmittel
ATE247948T1 (de) * 1996-04-29 2003-09-15 Dura Pharma Inc Verfahren zum inhalieren trockener pulver
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
ATE385193T1 (de) 2002-03-20 2008-02-15 Mannkind Corp Inhalationsgerät
RU2216353C1 (ru) * 2002-10-16 2003-11-20 Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова РАМН Способ получения гранулированной лекарственной формы из аллергена клещей рода dermatophagoides farinae
DE602005024413D1 (de) 2004-08-20 2010-12-09 Mannkind Corp Katalyse der diketopiperazinsynthese
CN104436170B (zh) 2004-08-23 2018-02-23 曼金德公司 用于药物输送的二酮哌嗪盐
JP5167133B2 (ja) 2005-09-14 2013-03-21 マンカインド コーポレイション 結晶性微粒子表面に対する活性薬剤の親和性の増大に基づく薬物処方の方法
MX2008010721A (es) 2006-02-22 2008-09-01 Mannkind Corp Un metodo para mejorar las propiedades farmaceuticas de microparticulas que contienen dicetopiperazina y un agente activo.
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
JP5421362B2 (ja) 2008-06-13 2014-02-19 マンカインド コーポレイション 薬物送達用の乾燥粉末吸入器およびシステム
RU2470681C2 (ru) 2008-06-20 2012-12-27 Маннкайнд Корпорейшн Интерактивное устройство и способ профилирования усилий при ингаляции в реальном масштабе времени
TWI614024B (zh) 2008-08-11 2018-02-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
EP2405963B1 (en) 2009-03-11 2013-11-06 MannKind Corporation Apparatus, system and method for measuring resistance of an inhaler
US8551528B2 (en) 2009-06-12 2013-10-08 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
EP2496295A1 (en) 2009-11-03 2012-09-12 MannKind Corporation An apparatus and method for simulating inhalation efforts
JP6385673B2 (ja) 2010-06-21 2018-09-05 マンカインド コーポレイション 乾燥粉末薬物送達システム
WO2012135765A2 (en) 2011-04-01 2012-10-04 Mannkind Corporation Blister package for pharmaceutical cartridges
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
IN2014DN03093A (cg-RX-API-DMAC7.html) 2011-10-24 2015-05-15 Mannkind Corp
AU2013289957B2 (en) 2012-07-12 2017-02-23 Mannkind Corporation Dry powder drug delivery systems and methods
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
ES2754388T3 (es) 2013-03-15 2020-04-17 Mannkind Corp Composiciones y métodos de dicetopiperazina microcristalina
AU2014290438B2 (en) 2013-07-18 2019-11-07 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
JP2016530930A (ja) 2013-08-05 2016-10-06 マンカインド コーポレイション 通気装置及び方法
WO2015148905A1 (en) 2014-03-28 2015-10-01 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3148121A (en) * 1960-01-27 1964-09-08 Miles Lab Water-insoluble whole inhalant complex and method of making same
GB1055465A (en) * 1962-09-27 1967-01-18 Vantorex Ltd Allergenic aerosol compositions
GB1182779A (en) * 1966-09-17 1970-03-04 Fisons Pharmaceuticals Ltd Inhalation Device
GB1247614A (en) * 1969-06-20 1971-09-29 Miles Lab Improved therapeutic and diagnostic allergenic extract and process for preparing same
BR6915418D0 (pt) * 1969-10-13 1973-03-13 Synergistics Inc Processo de preparacao de um composto antigeno de acaros e de seu soro e sua titulacao
GB1381872A (en) * 1971-06-22 1975-01-29 Fisons Ltd Pharmaceutical compositions for inhalation
US3995023A (en) * 1972-12-11 1976-11-30 Merck Patent Gesellschaft Mit Beschrankter Haftung Process for the production of allergen-containing extracts
NL7316346A (cg-RX-API-DMAC7.html) * 1972-12-11 1974-06-13
FR2466991A1 (fr) * 1979-10-08 1981-04-17 Pasteur Institut Perfectionnement a la preparation d'allergene

Also Published As

Publication number Publication date
IL65875A0 (en) 1982-08-31
IL65875A (en) 1986-09-30
NO156275B (no) 1987-05-18
CH650925A5 (it) 1985-08-30
NO156275C (no) 1987-08-26
US4681752A (en) 1987-07-21
DK239782A (da) 1982-12-05
GR76810B (cg-RX-API-DMAC7.html) 1984-09-04
JPH0575726B2 (cg-RX-API-DMAC7.html) 1993-10-21
DK153920C (da) 1989-02-06
EP0067130A3 (en) 1984-01-11
IT1220979B (it) 1990-06-21
IT8122136A0 (it) 1981-06-04
FR2512670A1 (fr) 1983-03-18
EP0067130B1 (en) 1986-06-25
EP0067130A2 (en) 1982-12-15
NO821832L (no) 1982-12-06
CA1207663A (en) 1986-07-15
JPS57212114A (en) 1982-12-27
ATE20518T1 (de) 1986-07-15
DE3271829D1 (en) 1986-07-31
DK153920B (da) 1988-09-26

Similar Documents

Publication Publication Date Title
FR2512670B1 (fr) Capsules contenant le principe actif d'un allergene et procede pour leur preparation
ES2117642T3 (es) Preparado farmaceutico que contiene n-glicofuroles y n-etilen glicoles.
ATE157257T1 (de) Verstärkung der unterdrückungsregulation von autoimmunkrankheiten durch orale oder enterale verabreichung von autoantigenen
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
BE838924A (fr) Nouveaux esters alkyliques d'acides 1,4-dihydropyridine-carboxyliques, leur procede de preparation et medicament les contenant
ES2137948T3 (es) Sistema avanzado de administracion de medicamentos y metodo de tratamiento de trastornos psiquiatricos, neurologicos y otros con carbamacepina.
BE885812A (fr) Derives d'acides 6beta-hydroxyalkylpenicillaniques, leur procede de production et compositions pharmaceutiques les contenant
EP0315591A3 (en) Physiologically active substances, a process for the preparation thereof and pharmaceutical compositions containing them
DE58901002D1 (de) Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken.
RU94045825A (ru) Применение материала, полученного из mycobacterium vaccae для производства терапевтического средства для лечения психических заболеваний, способ лечения психических заболеваний, продукт, содержащий антигенный и/или иммунорегуляторный материал, фармацевтическое средство
ES8102141A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7
Gutsell Sulfa drugs and the treatment of furunculosis in trout
FR2439194A1 (fr) Derives de la dibenzothiepine, leur procede de preparation et leur application therapeutique
FR2346005A1 (fr) Nouvelles lactones d'acides libres du type prostaglandine, leur procede de preparation et medicament les contenant
BE878836A (fr) Derives d'acide hydroxamique, leur procede de preparation et medicament les contenant
DE59107111D1 (de) 3,5-Diiod-L-Thyronin zur TSH-Suppression und Behandlung von Struma
SU315388A1 (ru) Лекарственное средство
Leek et al. Effect of monensin on experimental infections of Eimeria ninakohlyakimovae in lambs
ES2052475T1 (es) Preparacion farmaceutica para el tratamiento de trastornos inmunoorganicos comprendiendo pp14 o anticuerpos pp14.
FR2427822A1 (fr) Medicament pour le traitement des maladies circulatoires, a base de 5-methyl-7-dimethylamino-s-triazolo (1,5-a) pyrimidine
FR2321282A1 (fr) Arylamides d'acides o-aminoalkanoique, leur procede de preparation et leur application en therapeutique
BE881625A (fr) Esters o-alcoxycarbonyl-phenyliques d'un acide anthranilique leur preparation et compositions pharmaceutiques en contenant
BE863851A (fr) 2,4-dichlorophenyl-imidazolyl-ethanones ou -ethanols, leur procede de preparation et medicament les contenant
SU1326744A1 (ru) Способ активации фагоцитоза макрофагов IN VIтRо
FR2496658B1 (fr) Derives de l'acide nicotinique, leur preparation et medicament contenant ces substances

Legal Events

Date Code Title Description
CJ Change in legal form
CD Change of name or company name